MARKET WIRE NEWS

3 Biopharma Names I Am Buying After Avadel's Buyout

Source: SeekingAlpha

2025-10-26 09:45:35 ET

On Wednesday, Avadel Pharmaceuticals ( AVDL ) accepted a buyout off from Alkermes plc ( ALKS ) after settling litigation with Jazz Pharmaceuticals ( JAZZ ) . It should be noted this just the latest of several notable acquisitions since mid-September in this sector. Other companies purchased with significant buyout premiums include Merus N.V. ( MRUS ) , 89Bio, Inc. ( ETNB ) an Metsera, Inc. ( MTSR ) ....

Read the full article on Seeking Alpha

For further details see:

3 Biopharma Names I Am Buying After Avadel's Buyout
SPDR Series Trust S&P Biotech

NASDAQ: XBI

XBI Trading

-0.93% G/L:

$121.85 Last:

5,802,368 Volume:

$123.43 Open:

mwn-app Ad 300

XBI Latest News

February 11, 2026 10:11:00 am
Biotech Beat Nvidia in 2025. Can It Do It Again?

XBI Stock Data

$7,832,883,000
62,225,000
N/A
N/A
US

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App